Bringing to bear her years of experience working at the Office of Inspector General for the U.S. Department of Health and Human Services (HHS-OIG), Katie Dunn counsels healthcare clients in matters related to regulatory compliance, fraud and abuse, and government investigations. She helps clients respond to civil, criminal, and administrative enforcement actions, including those brought under the False Claims Act (FCA), Anti-Kickback Statute (AKS), and Stark Law. In addition, Katie aids healthcare providers with day-to-day operational challenges such as billing and reimbursement-related matters, compliance program development and effectiveness, and structuring of arrangements with referral sources. Finally, Katie helps buyers and sellers navigate the myriad federal and state regulatory requirements applicable to a healthcare transaction and work through complex compliance and operational issues that may arise.
American Health Law Association (AHLA)
American Bar Association
Tennessee Bar Association
Nashville Bar Association
Representation of Life Sciences Company Fagron Holding USA LLC
Represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions and in its underwritten public offering of 2.3 million shares of common stock in 2019.
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to HHS-OIG involving improper billing
Counsel to a private equity investment firm related to the financing of a complex buyout and restructuring of a company providing physician management and radiation oncology management services and cancer centers
Lead regulatory counsel to a private equity investment firm in its multi-billion dollar bid to take a publicly traded healthcare company private
Lead counsel for a large long-term care company named as a defendant in a FCA qui tam action involving allegations of medically unnecessary services and improper billing
Served as lead healthcare regulatory counsel to Amazon (Nasdaq: AMZN) in its acquisition of PillPack
HHS-OIG — Inspector General’s Award for Excellence in Fighting Fraud, Waste, and Abuse
Northeastern University Law Journal — Articles Editor
Tufts University — Presidential Award for Citizenship and Public Service